This fact improves the following activation of the migration and adhesion of genetically modified MSC due to the concentration gradient mediated by SDF-1α, TGF-β1 (transforming growth factor beta), and CCL2 (C-C motif ligand 2) around the tumor. The gene discussed is CXCL12; the disease is neoplasm.